A detailed history of Parallel Advisors, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Parallel Advisors, LLC holds 20,996 shares of AZN stock, worth $1.4 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
20,996
Previous 20,753 1.17%
Holding current value
$1.4 Million
Previous $1.62 Million 1.11%
% of portfolio
0.04%
Previous 0.04%

Shares

34 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$76.67 - $87.62 $18,630 - $21,291
243 Added 1.17%
20,996 $1.64 Million
Q2 2024

Aug 08, 2024

BUY
$66.81 - $80.83 $132,484 - $160,285
1,983 Added 10.56%
20,753 $1.62 Million
Q1 2024

May 06, 2024

BUY
$61.03 - $69.57 $272,071 - $310,143
4,458 Added 31.15%
18,770 $1.27 Million
Q4 2023

Feb 09, 2024

SELL
$61.89 - $69.28 $10,459 - $11,708
-169 Reduced 1.17%
14,312 $963,000
Q3 2023

May 20, 2024

BUY
$64.85 - $71.7 $42,152 - $46,605
650 Added 4.7%
14,481 $980,000
Q3 2023

Nov 13, 2023

BUY
$64.85 - $71.7 $42,152 - $46,605
650 Added 4.7%
14,481 $980,000
Q2 2023

May 20, 2024

BUY
$69.91 - $75.81 $29,851 - $32,370
427 Added 3.19%
13,831 $989,000
Q2 2023

Aug 04, 2023

BUY
$69.91 - $75.81 $29,851 - $32,370
427 Added 3.19%
13,831 $989,000
Q1 2023

May 20, 2024

SELL
$63.15 - $71.6 $338,862 - $384,205
-5,366 Reduced 28.59%
13,404 $930,000
Q1 2023

Apr 25, 2023

BUY
$63.15 - $71.6 $11,240 - $12,744
178 Added 1.35%
13,404 $930,000
Q4 2022

Feb 03, 2023

SELL
$54.21 - $70.44 $44,669 - $58,042
-824 Reduced 5.86%
13,226 $896,000
Q3 2022

Nov 10, 2022

BUY
$53.02 - $135.75 $137,852 - $352,950
2,600 Added 22.71%
14,050 $770,000
Q2 2022

Aug 01, 2022

SELL
$59.26 - $71.14 $13,511 - $16,219
-228 Reduced 1.95%
11,450 $757,000
Q1 2022

Apr 28, 2022

SELL
$55.72 - $67.12 $139,411 - $167,934
-2,502 Reduced 17.64%
11,678 $784,000
Q4 2021

Jan 20, 2022

BUY
$54.02 - $63.83 $12,046 - $14,234
223 Added 1.6%
14,180 $826,000
Q3 2021

Nov 02, 2021

BUY
$55.56 - $60.79 $126,010 - $137,871
2,268 Added 19.4%
13,957 $838,000
Q2 2021

Aug 06, 2021

BUY
$48.42 - $60.18 $31,715 - $39,417
655 Added 5.94%
11,689 $700,000
Q1 2021

Apr 23, 2021

SELL
$47.16 - $54.44 $29,427 - $33,970
-624 Reduced 5.35%
11,034 $549,000
Q4 2020

Feb 02, 2021

SELL
$48.52 - $58.02 $14,992 - $17,928
-309 Reduced 2.58%
11,658 $583,000
Q3 2020

Oct 27, 2020

BUY
$53.07 - $61.1 $9,871 - $11,364
186 Added 1.58%
11,967 $656,000
Q2 2020

Jul 16, 2020

SELL
$43.1 - $55.31 $10,904 - $13,993
-253 Reduced 2.1%
11,781 $623,000
Q1 2020

Apr 27, 2020

BUY
$37.79 - $51.33 $32,083 - $43,579
849 Added 7.59%
12,034 $537,000
Q4 2019

Jan 30, 2020

SELL
$42.46 - $50.46 $19,149 - $22,757
-451 Reduced 3.88%
11,185 $558,000
Q3 2019

Nov 01, 2019

BUY
$40.12 - $45.47 $45,135 - $51,153
1,125 Added 10.7%
11,636 $519,000
Q2 2019

Aug 05, 2019

SELL
$37.28 - $41.68 $40,262 - $45,014
-1,080 Reduced 9.32%
10,511 $434,000
Q1 2019

May 01, 2019

BUY
$35.49 - $43.02 $17,709 - $21,466
499 Added 4.5%
11,591 $469,000
Q4 2018

Feb 05, 2019

BUY
$36.86 - $41.49 $32,289 - $36,345
876 Added 8.57%
11,092 $421,000
Q3 2018

Nov 01, 2018

SELL
$34.76 - $39.72 $1,738 - $1,986
-50 Reduced 0.49%
10,216 $404,000
Q2 2018

Jul 30, 2018

BUY
$34.55 - $37.05 $1,243 - $1,333
36 Added 0.35%
10,266 $360,000
Q1 2018

May 08, 2018

BUY
$32.97 - $36.63 $31,849 - $35,384
966 Added 10.43%
10,230 $358,000
Q4 2017

Feb 13, 2018

SELL
$32.09 - $34.78 $8,279 - $8,973
-258 Reduced 2.71%
9,264 $321,000
Q3 2017

Nov 15, 2017

BUY
$28.96 - $34.0 $275,757 - $323,748
9,522 New
9,522 $313,000
Q3 2017

Nov 14, 2017

SELL
$28.96 - $34.0 $202,285 - $237,490
-6,985 Closed
0 $0
Q2 2017

Aug 07, 2017

BUY
N/A
6,985
6,985 $211,000

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $206B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Parallel Advisors, LLC Portfolio

Follow Parallel Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallel Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parallel Advisors, LLC with notifications on news.